GlassScriptPhysician profile
Rafael A Martinez
NPI 1629144795
$37,398.34
in general payments reported to CMS, 2019-2025
66 companies · $4,200 in 2025
The $4,200 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,735 · 2020: $2,793 · 2021: $3,389 · 2022: $3,700 · 2023: $16K · 2024: $4,399 · 2025: $4,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,585.58 |
| Education | $12,195.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,309.92 | 2023-2025 | Da Vinci Surgical System, Ion |
| Glaxosmithkline, LLC. | $4,787.05 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $3,164.81 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $2,074.98 | 2020-2025 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,373.60 | 2019-2025 | Ofev, Jascayd |
| Harmony Biosciences LLC | $1,121.42 | 2020-2025 | Wakix |
| Genzyme Corporation | $1,118.64 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,069.53 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $1,059.74 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $957.82 | 2019-2023 | Yupelri |
| Jazz Pharmaceuticals INC. | $863.06 | 2019-2025 | |
| Insmed, INC. | $796.32 | 2019-2025 | Arikayce, Brinsupri |
| Philips North America LLC | $595.46 | 2019-2025 | Image Management Subscription, (Ae4) Secretion Management, Vest Therapy Und |
| Amgen INC. | $529.76 | 2019-2025 | Tezspire |
| Bayer Healthcare Pharmaceuticals INC. | $522.17 | 2019-2024 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $483.88 | 2023-2025 | Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $453.68 | 2019-2024 | |
| Mallinckrodt Hospital Products INC. | $443.39 | 2021-2025 | Acthar |
| Baxter Healthcare | $360.95 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Vest System Model 205 Acute Care |
| Teva Pharmaceuticals USA, INC. | $348.21 | 2019-2023 | |
| United Therapeutics Corporation | $304.56 | 2020-2025 | Tyvaso, Tyvaso |
| Electromed, INC. | $245.66 | 2019-2024 | Smartvest |
| Verona Pharma, INC. | $202.50 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $198.10 | 2019-2021 | |
| Eisai INC. | $161.21 | 2020-2022 | |
| Genentech USA, INC. | $154.81 | 2019-2023 | Xolair |
| Actelion Pharmaceuticals US, INC. | $144.47 | 2022-2025 | Opsumit, Uptravi |
| Inogen, INC. | $137.61 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Advanced Respiratory, INC | $130.40 | 2019-2021 | |
| Pfizer INC. | $106.88 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $78.99 | 2024 | |
| Axsome Therapeutics, INC. | $76.28 | 2023-2025 | Sunosi |
| Idorsia Pharmaceuticals US INC | $71.86 | 2022-2023 | Quviviq |
| Shire North American Group INC | $58.36 | 2019 | |
| Abbott Laboratories | $57.22 | 2023-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Vapotherm INC | $56.89 | 2022 | |
| Shield Therapeutics INC | $56.72 | 2023-2024 | Accrufer |
| Merck Sharp & Dohme LLC | $54.88 | 2021-2023 | |
| Optinose US, INC. | $54.83 | 2019-2020 | |
| Circassia INC. | $51.83 | 2019 | |
| Covis Pharma Gmbh | $50.19 | 2022 | |
| Arbor Pharmaceuticals, INC. | $47.70 | 2019-2021 | |
| Pharming Healthcare, INC. | $44.03 | 2022-2023 | Ruconest |
| Azurity Pharmaceuticals, INC. | $43.01 | 2023-2024 | Horizant, Horizant |
| Paratek Pharmaceuticals, INC. | $40.52 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $40.50 | 2025 | Lumryz |
| Lilly USA, LLC | $35.51 | 2024-2025 | Zepbound |
| Phadia US INC. | $33.54 | 2021-2025 | Immunocap |
| Alk-Abello, INC | $32.64 | 2023 | Grastek, Ragwitek, Odactra |
| Ambu INC. | $31.28 | 2024 | |
| Fujifilm Healthcare Americas Corporation | $28.37 | 2024 | Fujifilm |
| Biogen, INC. | $27.07 | 2025 | Skyclarys |
| Nabriva Therapeutics, Plc | $23.58 | 2020 | |
| Resmed Corp | $20.10 | 2024 | |
| Sanofi Pasteur INC. | $20.02 | 2024 | |
| Pulmonx Corporation | $16.44 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Shionogi INC | $15.45 | 2021 | |
| 3b Medical, INC. | $9.94 | 2024 | Luna |
8 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.